A recent study reported that oral tongue (OSC19 and SCC61) or pharyngeal cancer (Detroit 562) cell-derived sEVs can induce Ephrin-B reverse signaling in endothelial cells and promote angiogenesis via Ephrin type B receptor 2 (EPHB2) [35]. Here, EPHB2 is linked to pharynx cancer.